Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9192616
APP PUB NO 20130065862A1
SERIAL NO

13439594

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SALIX PHARMACEUTICALS INC400 SOMERSET CORPORATE BLVD BRIDGEWATER NJ 08807

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johnson, Lorin Palo Alto, US 15 140

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00